Global Gabapentin Drug Market Research Report 2025(Status and Outlook)

March 2025 | 236 pages | ID: G483E3844A76EN
Bosson Research

Abstracts

Report Overview

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

This report provides a deep insight into the global Gabapentin Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gabapentin Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gabapentin Drug market in any manner.

Global Gabapentin Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

Depomed

Apotex

Teva

Acella Pharmaceuticals

Taro

Sun Pharmaceutical

Glenmark

Amneal Pharmaceuticals

Aurobindo Pharma

Zydus Pharmaceuticals

Hi-Tech Pharmaceuticals

Marksans Pharma

Mylan

InvaGen Pharmaceuticals

Alkem Laboratories

Tris Pharma

ACI HealthCare Limited

Jiangsu Hengrui Medicine

CSPC Ouyi Pharmaceutical

Sciegen Pharmaceuticals

Epic Pharma

Lupin Limited

Market Segmentation (by Type)

Capsule

Tablet

Oral Solution

Market Segmentation (by Application)

Postherpetic Neuralgia in Adults

Partial Onset Seizures

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Gabapentin Drug Market
• Overview of the regional outlook of the Gabapentin Drug Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gabapentin Drug
1.2 Key Market Segments
1.2.1 Gabapentin Drug Segment by Type
1.2.2 Gabapentin Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Gabapentin Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Gabapentin Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gabapentin Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Gabapentin Drug Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Gabapentin Drug Product Life Cycle
3.3 Global Gabapentin Drug Sales by Manufacturers (2020-2025)
3.4 Global Gabapentin Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gabapentin Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Gabapentin Drug Manufacturing Sites, Area Served, Product Type
3.8 Gabapentin Drug Market Competitive Situation and Trends
3.8.1 Gabapentin Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gabapentin Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Gabapentin Drug Industry Chain Analysis
4.1 Gabapentin Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gabapentin Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gabapentin Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Gabapentin Drug Market
5.7 ESG Ratings of Leading Companies
6 Global Gabapentin Drug Market by Region
6.1 Global Gabapentin Drug Market Size by Region
6.1.1 Global Gabapentin Drug Market Size by Region
6.1.2 Global Gabapentin Drug Market Size Market Share by Region
6.2 Global Gabapentin Drug Sales by Region
6.2.1 Global Gabapentin Drug Sales by Region
6.2.2 Global Gabapentin Drug Sales Market Share by Region
7 North America Market Overview
7.1 North America Gabapentin Drug Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Gabapentin Drug Market Size by Type
7.3 North America Gabapentin Drug Market Size by Application
8 Europe Market Overview
8.1 Europe Gabapentin Drug Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Gabapentin Drug Market Size by Type
8.3 Europe Gabapentin Drug Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Gabapentin Drug Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Gabapentin Drug Market Size by Type
9.3 Asia-Pacific Gabapentin Drug Market Size by Application
10 South America Market Overview
10.1 South America Gabapentin Drug Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Gabapentin Drug Market Size by Type
10.3 South America Gabapentin Drug Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Gabapentin Drug Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Gabapentin Drug Market Size by Type
11.3 Middle East and Africa Gabapentin Drug Market Size by Application
12 Gabapentin Drug Market Production by Region
12.1 Global Production of Gabapentin Drug by Region(2020-2025)
12.2 Global Gabapentin Drug Revenue Market Share by Region (2020-2025)
12.3 Global Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Gabapentin Drug Production
12.4.1 North America Gabapentin Drug Production Growth Rate (2020-2025)
12.4.2 North America Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Gabapentin Drug Production
12.5.1 Europe Gabapentin Drug Production Growth Rate (2020-2025)
12.5.2 Europe Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Gabapentin Drug Production (2020-2025)
12.6.1 Japan Gabapentin Drug Production Growth Rate (2020-2025)
12.6.2 Japan Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Gabapentin Drug Production (2020-2025)
12.7.1 China Gabapentin Drug Production Growth Rate (2020-2025)
12.7.2 China Gabapentin Drug Production, Revenue, Price and Gross Margin (2020-2025)
13 Gabapentin Drug Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Gabapentin Drug Sales Market Share by Type (2020-2033)
13.3 Global Gabapentin Drug Market Size Market Share by Type (2020-2033)
13.4 Global Gabapentin Drug Price by Type (2020-2033)
14 Gabapentin Drug Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Gabapentin Drug Market Sales by Application (2020-2033)
14.3 Global Gabapentin Drug Market Size (M USD) by Application (2020-2033)
14.4 Global Gabapentin Drug Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Pfizer
15.1.1 Pfizer Basic Information
15.1.2 Pfizer Gabapentin Drug Product Overview
15.1.3 Pfizer Gabapentin Drug Product Market Performance
15.1.4 Pfizer Business Overview
15.1.5 Pfizer SWOT Analysis
15.1.6 Pfizer Recent Developments
15.2 Depomed
15.2.1 Depomed Basic Information
15.2.2 Depomed Gabapentin Drug Product Overview
15.2.3 Depomed Gabapentin Drug Product Market Performance
15.2.4 Depomed Business Overview
15.2.5 Depomed SWOT Analysis
15.2.6 Depomed Recent Developments
15.3 Apotex
15.3.1 Apotex Basic Information
15.3.2 Apotex Gabapentin Drug Product Overview
15.3.3 Apotex Gabapentin Drug Product Market Performance
15.3.4 Apotex Business Overview
15.3.5 Apotex SWOT Analysis
15.3.6 Apotex Recent Developments
15.4 Teva
15.4.1 Teva Basic Information
15.4.2 Teva Gabapentin Drug Product Overview
15.4.3 Teva Gabapentin Drug Product Market Performance
15.4.4 Teva Business Overview
15.4.5 Teva Recent Developments
15.5 Acella Pharmaceuticals
15.5.1 Acella Pharmaceuticals Basic Information
15.5.2 Acella Pharmaceuticals Gabapentin Drug Product Overview
15.5.3 Acella Pharmaceuticals Gabapentin Drug Product Market Performance
15.5.4 Acella Pharmaceuticals Business Overview
15.5.5 Acella Pharmaceuticals Recent Developments
15.6 Taro
15.6.1 Taro Basic Information
15.6.2 Taro Gabapentin Drug Product Overview
15.6.3 Taro Gabapentin Drug Product Market Performance
15.6.4 Taro Business Overview
15.6.5 Taro Recent Developments
15.7 Sun Pharmaceutical
15.7.1 Sun Pharmaceutical Basic Information
15.7.2 Sun Pharmaceutical Gabapentin Drug Product Overview
15.7.3 Sun Pharmaceutical Gabapentin Drug Product Market Performance
15.7.4 Sun Pharmaceutical Business Overview
15.7.5 Sun Pharmaceutical Recent Developments
15.8 Glenmark
15.8.1 Glenmark Basic Information
15.8.2 Glenmark Gabapentin Drug Product Overview
15.8.3 Glenmark Gabapentin Drug Product Market Performance
15.8.4 Glenmark Business Overview
15.8.5 Glenmark Recent Developments
15.9 Amneal Pharmaceuticals
15.9.1 Amneal Pharmaceuticals Basic Information
15.9.2 Amneal Pharmaceuticals Gabapentin Drug Product Overview
15.9.3 Amneal Pharmaceuticals Gabapentin Drug Product Market Performance
15.9.4 Amneal Pharmaceuticals Business Overview
15.9.5 Amneal Pharmaceuticals Recent Developments
15.10 Aurobindo Pharma
15.10.1 Aurobindo Pharma Basic Information
15.10.2 Aurobindo Pharma Gabapentin Drug Product Overview
15.10.3 Aurobindo Pharma Gabapentin Drug Product Market Performance
15.10.4 Aurobindo Pharma Business Overview
15.10.5 Aurobindo Pharma Recent Developments
15.11 Zydus Pharmaceuticals
15.11.1 Zydus Pharmaceuticals Basic Information
15.11.2 Zydus Pharmaceuticals Gabapentin Drug Product Overview
15.11.3 Zydus Pharmaceuticals Gabapentin Drug Product Market Performance
15.11.4 Zydus Pharmaceuticals Business Overview
15.11.5 Zydus Pharmaceuticals Recent Developments
15.12 Hi-Tech Pharmaceuticals
15.12.1 Hi-Tech Pharmaceuticals Basic Information
15.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
15.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Product Market Performance
15.12.4 Hi-Tech Pharmaceuticals Business Overview
15.12.5 Hi-Tech Pharmaceuticals Recent Developments
15.13 Marksans Pharma
15.13.1 Marksans Pharma Basic Information
15.13.2 Marksans Pharma Gabapentin Drug Product Overview
15.13.3 Marksans Pharma Gabapentin Drug Product Market Performance
15.13.4 Marksans Pharma Business Overview
15.13.5 Marksans Pharma Recent Developments
15.14 Mylan
15.14.1 Mylan Basic Information
15.14.2 Mylan Gabapentin Drug Product Overview
15.14.3 Mylan Gabapentin Drug Product Market Performance
15.14.4 Mylan Business Overview
15.14.5 Mylan Recent Developments
15.15 InvaGen Pharmaceuticals
15.15.1 InvaGen Pharmaceuticals Basic Information
15.15.2 InvaGen Pharmaceuticals Gabapentin Drug Product Overview
15.15.3 InvaGen Pharmaceuticals Gabapentin Drug Product Market Performance
15.15.4 InvaGen Pharmaceuticals Business Overview
15.15.5 InvaGen Pharmaceuticals Recent Developments
15.16 Alkem Laboratories
15.16.1 Alkem Laboratories Basic Information
15.16.2 Alkem Laboratories Gabapentin Drug Product Overview
15.16.3 Alkem Laboratories Gabapentin Drug Product Market Performance
15.16.4 Alkem Laboratories Business Overview
15.16.5 Alkem Laboratories Recent Developments
15.17 Tris Pharma
15.17.1 Tris Pharma Basic Information
15.17.2 Tris Pharma Gabapentin Drug Product Overview
15.17.3 Tris Pharma Gabapentin Drug Product Market Performance
15.17.4 Tris Pharma Business Overview
15.17.5 Tris Pharma Recent Developments
15.18 ACI HealthCare Limited
15.18.1 ACI HealthCare Limited Basic Information
15.18.2 ACI HealthCare Limited Gabapentin Drug Product Overview
15.18.3 ACI HealthCare Limited Gabapentin Drug Product Market Performance
15.18.4 ACI HealthCare Limited Business Overview
15.18.5 ACI HealthCare Limited Recent Developments
15.19 Jiangsu Hengrui Medicine
15.19.1 Jiangsu Hengrui Medicine Basic Information
15.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
15.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Product Market Performance
15.19.4 Jiangsu Hengrui Medicine Business Overview
15.19.5 Jiangsu Hengrui Medicine Recent Developments
15.20 CSPC Ouyi Pharmaceutical
15.20.1 CSPC Ouyi Pharmaceutical Basic Information
15.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
15.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Market Performance
15.20.4 CSPC Ouyi Pharmaceutical Business Overview
15.20.5 CSPC Ouyi Pharmaceutical Recent Developments
15.21 Sciegen Pharmaceuticals
15.21.1 Sciegen Pharmaceuticals Basic Information
15.21.2 Sciegen Pharmaceuticals Gabapentin Drug Product Overview
15.21.3 Sciegen Pharmaceuticals Gabapentin Drug Product Market Performance
15.21.4 Sciegen Pharmaceuticals Business Overview
15.21.5 Sciegen Pharmaceuticals Recent Developments
15.22 Epic Pharma
15.22.1 Epic Pharma Basic Information
15.22.2 Epic Pharma Gabapentin Drug Product Overview
15.22.3 Epic Pharma Gabapentin Drug Product Market Performance
15.22.4 Epic Pharma Business Overview
15.22.5 Epic Pharma Recent Developments
15.23 Lupin Limited
15.23.1 Lupin Limited Basic Information
15.23.2 Lupin Limited Gabapentin Drug Product Overview
15.23.3 Lupin Limited Gabapentin Drug Product Market Performance
15.23.4 Lupin Limited Business Overview
15.23.5 Lupin Limited Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gabapentin Drug Market Size by Type (M USD)
Table 4. Global Gabapentin Drug Market Size by Application (M USD)
Table 5. Gabapentin Drug Market Size Comparison by Region (M USD)
Table 6. Global Gabapentin Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gabapentin Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gabapentin Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gabapentin Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2024)
Table 11. Global Market Gabapentin Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Gabapentin Drug Manufacturing Sites and Area Served
Table 13. Manufacturers Gabapentin Drug Product Type
Table 14. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Gabapentin Drug Market Size Comparison by Region (M USD)
Table 26. Global Gabapentin Drug Market Size by Region (2020-2033) & (M USD)
Table 27. Global Gabapentin Drug Market Size Market Share by Region (2020-2033)
Table 28. Global Gabapentin Drug Sales by Region (2020-2033) & (K MT)
Table 29. Global Gabapentin Drug Sales Market Share by Region (2020-2033)
Table 30. North America Gabapentin Drug Market Size by Country (2020-2033) & (M USD)
Table 31. North America Gabapentin Drug Sales by Country (2020-2033) & (K MT)
Table 32. North America Gabapentin Drug Sales by Type (K MT)
Table 33. North America Gabapentin Drug Market Size by Type (M USD)
Table 34. North America Gabapentin Drug Sales (K MT) by Type (2020-2033)
Table 35. North America Gabapentin Drug Market Size (M USD) by Type (2020-2033)
Table 36. North America Gabapentin Drug Sales by Application (K MT)
Table 37. North America Gabapentin Drug Market Size by Application (M USD)
Table 38. North America Gabapentin Drug Sales (K MT) by Application (2020-2033)
Table 39. North America Gabapentin Drug Market Size (M USD) by Application (2020-2033)
Table 40. Europe Gabapentin Drug Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Gabapentin Drug Sales by Country (2020-2033) & (K MT)
Table 42. Europe Gabapentin Drug Sales by Type (K MT)
Table 43. Europe Gabapentin Drug Market Size by Type (M USD)
Table 44. Europe Gabapentin Drug Sales (K MT) by Type (2020-2033)
Table 45. Europe Gabapentin Drug Market Size (M USD) by Type (2020-2033)
Table 46. Europe Gabapentin Drug Sales by Application (K MT)
Table 47. Europe Gabapentin Drug Market Size by Application (M USD)
Table 48. Europe Gabapentin Drug Sales (K MT) by Application (2020-2033)
Table 49. Europe Gabapentin Drug Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Gabapentin Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Gabapentin Drug Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Gabapentin Drug Sales by Type (K MT)
Table 53. Asia-Pacific Gabapentin Drug Market Size by Type (M USD)
Table 54. Asia-Pacific Gabapentin Drug Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Gabapentin Drug Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Gabapentin Drug Sales by Application (K MT)
Table 57. Asia-Pacific Gabapentin Drug Market Size by Application (M USD)
Table 58. Asia-Pacific Gabapentin Drug Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Gabapentin Drug Market Size (M USD) by Application (2020-2025)
Table 60. South America Gabapentin Drug Market Size by Country (2020-2033) & (M USD)
Table 61. South America Gabapentin Drug Sales by Country (2020-2033) & (K MT)
Table 62. South America Gabapentin Drug Sales by Type (K MT)
Table 63. South America Gabapentin Drug Market Size by Type (M USD)
Table 64. South America Gabapentin Drug Sales (K MT) by Type (2020-2033)
Table 65. South America Gabapentin Drug Market Size (M USD) by Type (2020-2033)
Table 66. South America Gabapentin Drug Sales by Application (K MT)
Table 67. South America Gabapentin Drug Market Size by Application (M USD)
Table 68. South America Gabapentin Drug Sales (K MT) by Application (2020-2033)
Table 69. South America Gabapentin Drug Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Gabapentin Drug Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Gabapentin Drug Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Gabapentin Drug Sales by Type (K MT)
Table 73. Middle East and Africa Gabapentin Drug Market Size by Type (M USD)
Table 74. Middle East and Africa Gabapentin Drug Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Gabapentin Drug Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Gabapentin Drug Sales by Application (K MT)
Table 77. Middle East and Africa Gabapentin Drug Market Size by Application (M USD)
Table 78. Middle East and Africa Gabapentin Drug Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Gabapentin Drug Market Size (M USD) by Application (2020-2033)
Table 80. Global Gabapentin Drug Production (K MT) by Region(2020-2025)
Table 81. Global Gabapentin Drug Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Gabapentin Drug Revenue Market Share by Region (2020-2025)
Table 83. Global Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Gabapentin Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Gabapentin Drug Sales by Type (K MT)
Table 89. Global Gabapentin Drug Market Size by Type (M USD)
Table 90. Global Gabapentin Drug Sales (K MT) by Type (2020-2033)
Table 91. Global Gabapentin Drug Sales Market Share by Type (2020-2033)
Table 92. Global Gabapentin Drug Market Size (M USD) by Type (2020-2033)
Table 93. Global Gabapentin Drug Market Size Share by Type (2020-2033)
Table 94. Global Gabapentin Drug Sales (K MT) by Application
Table 95. Global Gabapentin Drug Market Size by Application(M USD)
Table 96. Global Gabapentin Drug Sales by Application (2020-2033) & (K MT)
Table 97. Global Gabapentin Drug Sales Market Share by Application (2020-2033)
Table 98. Global Gabapentin Drug Market Size by Application (2020-2033) & (M USD)
Table 99. Global Gabapentin Drug Market Share by Application (2020-2033)
Table 100. Global Gabapentin Drug Sales Growth Rate by Application (2020-2033)
Table 101. Pfizer Basic Information
Table 102. Pfizer Gabapentin Drug Product Overview
Table 103. Pfizer Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Pfizer Business Overview
Table 105. Pfizer SWOT Analysis
Table 106. Pfizer Recent Developments
Table 107. Depomed Basic Information
Table 108. Depomed Gabapentin Drug Product Overview
Table 109. Depomed Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Depomed Business Overview
Table 111. Depomed SWOT Analysis
Table 112. Depomed Recent Developments
Table 113. Apotex Basic Information
Table 114. Apotex Gabapentin Drug Product Overview
Table 115. Apotex Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Apotex Business Overview
Table 117. Apotex SWOT Analysis
Table 118. Apotex Recent Developments
Table 119. Teva Basic Information
Table 120. Teva Gabapentin Drug Product Overview
Table 121. Teva Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Teva Business Overview
Table 123. Teva Recent Developments
Table 124. Acella Pharmaceuticals Basic Information
Table 125. Acella Pharmaceuticals Gabapentin Drug Product Overview
Table 126. Acella Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Acella Pharmaceuticals Business Overview
Table 128. Acella Pharmaceuticals Recent Developments
Table 129. Taro Basic Information
Table 130. Taro Gabapentin Drug Product Overview
Table 131. Taro Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Taro Business Overview
Table 133. Taro Recent Developments
Table 134. Sun Pharmaceutical Basic Information
Table 135. Sun Pharmaceutical Gabapentin Drug Product Overview
Table 136. Sun Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Sun Pharmaceutical Business Overview
Table 138. Sun Pharmaceutical Recent Developments
Table 139. Glenmark Basic Information
Table 140. Glenmark Gabapentin Drug Product Overview
Table 141. Glenmark Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Glenmark Business Overview
Table 143. Glenmark Recent Developments
Table 144. Amneal Pharmaceuticals Basic Information
Table 145. Amneal Pharmaceuticals Gabapentin Drug Product Overview
Table 146. Amneal Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Amneal Pharmaceuticals Business Overview
Table 148. Amneal Pharmaceuticals Recent Developments
Table 149. Aurobindo Pharma Basic Information
Table 150. Aurobindo Pharma Gabapentin Drug Product Overview
Table 151. Aurobindo Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Aurobindo Pharma Business Overview
Table 153. Aurobindo Pharma Recent Developments
Table 154. Zydus Pharmaceuticals Basic Information
Table 155. Zydus Pharmaceuticals Gabapentin Drug Product Overview
Table 156. Zydus Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Zydus Pharmaceuticals Business Overview
Table 158. Zydus Pharmaceuticals Recent Developments
Table 159. Hi-Tech Pharmaceuticals Basic Information
Table 160. Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
Table 161. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Hi-Tech Pharmaceuticals Business Overview
Table 163. Hi-Tech Pharmaceuticals Recent Developments
Table 164. Marksans Pharma Basic Information
Table 165. Marksans Pharma Gabapentin Drug Product Overview
Table 166. Marksans Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Marksans Pharma Business Overview
Table 168. Marksans Pharma Recent Developments
Table 169. Mylan Basic Information
Table 170. Mylan Gabapentin Drug Product Overview
Table 171. Mylan Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Mylan Business Overview
Table 173. Mylan Recent Developments
Table 174. InvaGen Pharmaceuticals Basic Information
Table 175. InvaGen Pharmaceuticals Gabapentin Drug Product Overview
Table 176. InvaGen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. InvaGen Pharmaceuticals Business Overview
Table 178. InvaGen Pharmaceuticals Recent Developments
Table 179. Alkem Laboratories Basic Information
Table 180. Alkem Laboratories Gabapentin Drug Product Overview
Table 181. Alkem Laboratories Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Alkem Laboratories Business Overview
Table 183. Alkem Laboratories Recent Developments
Table 184. Tris Pharma Basic Information
Table 185. Tris Pharma Gabapentin Drug Product Overview
Table 186. Tris Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Tris Pharma Business Overview
Table 188. Tris Pharma Recent Developments
Table 189. ACI HealthCare Limited Basic Information
Table 190. ACI HealthCare Limited Gabapentin Drug Product Overview
Table 191. ACI HealthCare Limited Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. ACI HealthCare Limited Business Overview
Table 193. ACI HealthCare Limited Recent Developments
Table 194. Jiangsu Hengrui Medicine Basic Information
Table 195. Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
Table 196. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Jiangsu Hengrui Medicine Business Overview
Table 198. Jiangsu Hengrui Medicine Recent Developments
Table 199. CSPC Ouyi Pharmaceutical Basic Information
Table 200. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
Table 201. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. CSPC Ouyi Pharmaceutical Business Overview
Table 203. CSPC Ouyi Pharmaceutical Recent Developments
Table 204. Sciegen Pharmaceuticals Basic Information
Table 205. Sciegen Pharmaceuticals Gabapentin Drug Product Overview
Table 206. Sciegen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Sciegen Pharmaceuticals Business Overview
Table 208. Sciegen Pharmaceuticals Recent Developments
Table 209. Epic Pharma Basic Information
Table 210. Epic Pharma Gabapentin Drug Product Overview
Table 211. Epic Pharma Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. Epic Pharma Business Overview
Table 213. Epic Pharma Recent Developments
Table 214. Lupin Limited Basic Information
Table 215. Lupin Limited Gabapentin Drug Product Overview
Table 216. Lupin Limited Gabapentin Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 217. Lupin Limited Business Overview
Table 218. Lupin Limited Recent Developments
List of Figures
Figure 1. Product Picture of Gabapentin Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Drug Market Size (M USD), 2024-2033
Figure 5. Global Gabapentin Drug Market Size (M USD) (2020-2033)
Figure 6. Global Gabapentin Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gabapentin Drug Product Life Cycle
Figure 13. Gabapentin Drug Sales Share by Manufacturers in 2024
Figure 14. Global Gabapentin Drug Revenue Share by Manufacturers in 2024
Figure 15. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gabapentin Drug Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gabapentin Drug Revenue in 2024
Figure 18. Industry Chain Map of Gabapentin Drug
Figure 19. Global Gabapentin Drug Market PEST Analysis
Figure 20. Global Gabapentin Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Gabapentin Drug Market Size by Region
Figure 27. Global Gabapentin Drug Market Size Market Share by Region (2020-2033)
Figure 28. Global Gabapentin Drug Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Gabapentin Drug Market Size (M USD) by Country
Figure 33. USA Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Gabapentin Drug Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Gabapentin Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Gabapentin Drug Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Gabapentin Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Gabapentin Drug Market Size (M USD)by Type
Figure 40. North America Gabapentin Drug Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Gabapentin Drug Market Size (M USD) by Country
Figure 45. Germany Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Gabapentin Drug Market Size (M USD) by Type
Figure 56. Europe Gabapentin Drug Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Gabapentin Drug Market Size (M USD) by Country
Figure 61. China Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Gabapentin Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Gabapentin Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Gabapentin Drug Market Size (M USD) by Type
Figure 72. Asia-Pacific Gabapentin Drug Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Gabapentin Drug Market Size (M USD) by Country
Figure 77. Brazil Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Gabapentin Drug Market Size (M USD) by Type
Figure 84. South America Gabapentin Drug Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Gabapentin Drug Market Size (M USD) by Country
Figure 89. Saudi Arabia Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Gabapentin Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Gabapentin Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Gabapentin Drug Market Size (M USD) by Type
Figure 100. Middle East and Africa Gabapentin Drug Market Size (M USD) by Application
Figure 101. Global Gabapentin Drug Production Market Share by Region (2020-2025)
Figure 102. North America Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. China Gabapentin Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Gabapentin Drug Market Size by Type (M USD)
Figure 108. Sales Market Share of Gabapentin Drug by Type (2020-2033)
Figure 109. Sales Market Share of Gabapentin Drug by Type in 2024
Figure 110. Market Size Share of Gabapentin Drug by Type (2020-2033)
Figure 111. Market Size Share of Gabapentin Drug by Type in 2024
Figure 112. Global Gabapentin Drug Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Gabapentin Drug Market Size by Application(M USD)
Figure 115. Global Gabapentin Drug Market Share by Application
Figure 116. Global Gabapentin Drug Sales Market Share by Application (2020-2033)
Figure 117. Global Gabapentin Drug Sales Market Share by Application in 2024
Figure 118. Global Gabapentin Drug Market Share by Application (2020-2033)
Figure 119. Global Gabapentin Drug Market Share by Application in 2024
Figure 120. Global Gabapentin Drug Sales Growth Rate by Application (2020-2033)